Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT.
Devillier R, Eikema DJ, Dufour C, Aljurf M, Wu D, Maschan A, Kulagin A, Halkes CJM, Collin M, Snowden J, Renard C, Ganser A, Sykora KW, Gibson BE, Maertens J, Itäla-Remes M, Corti P, Cornelissen J, Bornhäuser M, Araujo MC, Ozdogu H, Risitano A, Socie G, De Latour RP. Devillier R, et al. Haematologica. 2023 Sep 1;108(9):2305-2315. doi: 10.3324/haematol.2022.281876. Haematologica. 2023. PMID: 36951165 Free PMC article.
[Haploidentical hematopoietic stem cell transplant: How to choose the best donor? Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Dubois V, Amokrane K, Beguin Y, Bruno B, Chevallier P, Delbos F, Devillier R, Giannoli C, Guidicelli G, Harif M, Loiseau P, Rouzaire PO, Varlet P, Yakoub-Agha I, Nguyen S. Dubois V, et al. Among authors: devillier r. Bull Cancer. 2020 Jan;107(1S):S72-S84. doi: 10.1016/j.bulcan.2019.07.011. Epub 2019 Oct 2. Bull Cancer. 2020. PMID: 31586527 Free article. Review. French.
Myeloid malignancies: mutations, models and management.
Murati A, Brecqueville M, Devillier R, Mozziconacci MJ, Gelsi-Boyer V, Birnbaum D. Murati A, et al. Among authors: devillier r. BMC Cancer. 2012 Jul 23;12:304. doi: 10.1186/1471-2407-12-304. BMC Cancer. 2012. PMID: 22823977 Free PMC article. Review.
Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells.
Cauchois R, Castagna L, Pagliardini T, Harbi S, Calmels B, Bramanti S, Granata A, Lemarie C, Maisano V, Legrand F, Fürst S, Faucher C, Weiller PJ, Chabannon C, Blaise D, Devillier R. Cauchois R, et al. Among authors: devillier r. Br J Haematol. 2019 May;185(3):570-573. doi: 10.1111/bjh.15544. Epub 2018 Aug 20. Br J Haematol. 2019. PMID: 30125934 Free article. No abstract available.
Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma.
Mariotti J, Bramanti S, Devillier R, Furst S, El Cheikh J, Sarina B, Granata A, Faucher C, Harbi S, Morabito L, Weiller PJ, Chabannon C, Mokart J, Mineri R, Carlo-Stella C, Santoro A, Blaise D, Castagna L. Mariotti J, et al. Among authors: devillier r. Bone Marrow Transplant. 2018 Mar;53(3):366-370. doi: 10.1038/s41409-017-0032-1. Epub 2017 Dec 21. Bone Marrow Transplant. 2018. PMID: 29269800 No abstract available.
IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.
Caillet A, Simonet-Boissard M, Forcade E, Robin M, Rubio MT, Couturier MA, Srour M, Maillard N, Devillier R, Huynh A, Bourhis JH, Simand C, Chantepie S, Boisson C, Kroemer M, Deconinck E, Berceanu A. Caillet A, et al. Among authors: devillier r. Hemasphere. 2024 Mar 10;8(3):e44. doi: 10.1002/hem3.44. eCollection 2024 Mar. Hemasphere. 2024. PMID: 38469458 Free PMC article. No abstract available.
[PD-L1 glycosylation under the spotlights].
Olive D, Chrétien AS, Devillier R, Rochigneux P, Gorvel L, Nunès J. Olive D, et al. Among authors: devillier r. Med Sci (Paris). 2020 Jun-Jul;36(6-7):552-555. doi: 10.1051/medsci/2020099. Epub 2020 Jul 2. Med Sci (Paris). 2020. PMID: 32614301 Free article. French. No abstract available.
Manufacturing Natural Killer Cells as Medicinal Products.
Chabannon C, Mfarrej B, Guia S, Ugolini S, Devillier R, Blaise D, Vivier E, Calmels B. Chabannon C, et al. Among authors: devillier r. Front Immunol. 2016 Nov 15;7:504. doi: 10.3389/fimmu.2016.00504. eCollection 2016. Front Immunol. 2016. PMID: 27895646 Free PMC article. Review.
Epigenetically centered evolution in an example of myeloid malignancy.
Adélaide J, Cervera N, Carbuccia N, Garnier S, Guille A, Mozziconnaci MJ, Devillier R, Chaffanet M, Vey N, Birnbaum D, Gelsi-Boyer V. Adélaide J, et al. Among authors: devillier r. Am J Hematol. 2016 Sep;91(9):E361-2. doi: 10.1002/ajh.24450. Epub 2016 Jul 4. Am J Hematol. 2016. PMID: 27299509 Free article. No abstract available.
106 results